|
|
|
|
|
|
|
Poorly Soluble Drugs
How can we improve
dissolution, solubility and bioavailability? |
|
15th - 16th April 2009,
The Lakeside Centre, Aston University, Birmingham, UK |
|
|
|
Poor bioavailability of
active compounds is a major problem in drug delivery research and
development. Often the reason for this is poor aqueous solubility of the
drug. For most pharmaceutical companies many drugs in the pipeline fall into
class II of the biopharmaceutical classification systems. Depending on the
properties of the molecule, these compounds require different formulation
strategies to increase their dissolution rate, solubility, and ultimately
bioavailability. This workshop will give an overview about the various
formulation strategies that may be used to improve bioavailability of poorly
water soluble drugs. Industrial and academic perspectives on the link
between dissolution, solubility and bioavailability will be given and recent
developments in the formulation of these problem drugs will be discussed. |
|
|
|
What would you like to do:
|
|
|
|
|
Download the Programme and Registration Form